1-2 of 2
Tim H. Brümmendorf, Prof MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frequency of CTLA-4 Receptor Ligand (CD86, B7.2) -Positive Plasmacytoid Dendritic Cells Predicts Risk of Disease Recurrence after Tyrosine-Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Results from a Prospective Substudy of the Euroski Trial

Andreas Burchert, MD, Sabrina Inselmann, Susanne Saussele, Christian T. Dietz, PhD, Martin C. Müller, MD, Ekkehard Eigendorff, MD, Tim H. Brümmendorf, Prof MD, Cornelius Waller, MD, Jolanta Dengler, MD, Maria Elisabeth Goebeler, MD, Regina Herbst, MD, Gernot Freunek, MD, Stefan Hanzel, MD, Thomas Illmer, MD, Ying Wang, MD, Andreas Neubauer, MD, Thoralf Lange, MD, Andreas Hochhaus, MD, Finkernagel Florian, Cornelia A. Brendel, MD, Joelle Guilhot, PhD, Francois Xavier Mahon, MD PhD, Christin Schütz
Journal: Blood
Blood (2015) 126 (23): 599.
https://doi.org/10.1182/blood.V126.23.599.599
Published: 2015
Journal Articles

BGB324 Inhibits BCR-ABL TKI-Resistant Chronic Myeloid Leukemia

Isabel Ben Batalla, PhD, Robert Erdmann, PhD, Heather Jørgensen, PhD, Rebecca Mitchell, Thomas Ernst, MD, Gunhild von Amsberg, MD, Philippe Schafhausen, MD, Stephen Rankin, MD, Richard E. Clark, Prof MD, Steffen Koschmieder, MD, Alexander Schultze, MD, Subir Mitra, MD, Peter Vandenberghe, Prof MD PhD, Tim H. Brümmendorf, Prof MD, Peter Carmeliet, Prof MD PhD, Gudmundur Helgason, PhD, Andreas Hochhaus, MD, Klaus Pantel, Prof MD PhD, Carsten Bokemeyer, MD, Tessa L Holyoake, Prof PhD, Sonja Loges, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1569.
https://doi.org/10.1182/blood.V126.23.1569.1569
Published: 2015